These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38752346)

  • 1. Ecological evidence for melanoma overdiagnosis in Denmark.
    Olsen CM
    Br J Dermatol; 2024 May; ():. PubMed ID: 38752346
    [No Abstract]   [Full Text] [Related]  

  • 2. Overdiagnosis in malignant melanoma: a scoping review.
    Bjørch MF; Gram EG; Brodersen JB
    BMJ Evid Based Med; 2024 Jan; 29(1):17-28. PubMed ID: 37793786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatopathologist Perceptions of Overdiagnosis of Melanocytic Skin Lesions and Association With Diagnostic Behaviors.
    Kerr KF; Eguchi MM; Piepkorn MW; Radick AC; Reisch LM; Shucard HL; Knezevich SR; Barnhill RL; Elder DE; Elmore JG
    JAMA Dermatol; 2022 Jun; 158(6):675-679. PubMed ID: 35442415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing melanoma incidence with unchanged mortality: more sunshine, better treatment, increased diagnostic activity, overdiagnosis or lowered diagnostic threshold?
    Nielsen JB; Kristiansen IS; Thapa S
    Br J Dermatol; 2024 Apr; ():. PubMed ID: 38655629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975-2017.
    Kurtansky NR; Dusza SW; Halpern AC; Hartman RI; Geller AC; Marghoob AA; Rotemberg VM; Marchetti MA
    J Invest Dermatol; 2022 Jul; 142(7):1804-1811.e6. PubMed ID: 34902365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US.
    Adamson AS; Suarez EA; Welch HG
    JAMA Dermatol; 2022 Apr; 158(4):426-431. PubMed ID: 35293957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of cutaneous malignant melanoma in Denmark, 1978-2007.
    Fuglede NB; Brinck-Claussen UØ; Deltour I; Boesen EH; Dalton SO; Johansen C
    Br J Dermatol; 2011 Aug; 165(2):349-53. PubMed ID: 21466535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence concerning the accusation that melanoma is overdiagnosed.
    Muzumdar S; Lin G; Kerr P; Grant-Kels JM
    J Am Acad Dermatol; 2021 Oct; 85(4):841-846. PubMed ID: 34116095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods.
    Carter JL; Coletti RJ; Harris RP
    BMJ; 2015 Jan; 350():g7773. PubMed ID: 25569206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic error, uncertainty, and overdiagnosis in melanoma.
    Elder DE; Eguchi MM; Barnhill RL; Kerr KF; Knezevich SR; Piepkorn MW; Reisch LM; Elmore JG
    Pathology; 2023 Mar; 55(2):206-213. PubMed ID: 36642569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimations of overdiagnosis in breast cancer screening vary between 0% and over 50%: why?
    Chaltiel D; Hill C
    BMJ Open; 2021 Jun; 11(6):e046353. PubMed ID: 34158298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
    Jørgensen KJ; Gøtzsche PC; Kalager M; Zahl PH
    Ann Intern Med; 2017 Mar; 166(5):313-323. PubMed ID: 28114661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma Overdiagnosis Is Not the Key Problem-Reply.
    Adamson AS; Suarez EA; Welch HG
    JAMA Dermatol; 2022 Sep; 158(9):1083-1084. PubMed ID: 35895049
    [No Abstract]   [Full Text] [Related]  

  • 14. Melanoma Overdiagnosis Is Not the Key Problem.
    Paiva ML; Weinstock MA
    JAMA Dermatol; 2022 Sep; 158(9):1082-1083. PubMed ID: 35895044
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on "An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975-2017".
    Harms PW; Chan MP; Bresler SC; Andea AA; Hristov AC; Fullen DR; Patel RM; Lowe L
    J Invest Dermatol; 2022 Nov; 142(11):3120-3122. PubMed ID: 36273837
    [No Abstract]   [Full Text] [Related]  

  • 16. As you like it: How the same data can support manifold views of overdiagnosis in breast cancer screening.
    Njor SH; Paci E; Rebolj M
    Int J Cancer; 2018 Sep; 143(6):1287-1294. PubMed ID: 29633249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the magnitude of cancer overdiagnosis in Australia.
    Glasziou PP; Jones MA; Pathirana T; Barratt AL; Bell KJ
    Med J Aust; 2020 Mar; 212(4):163-168. PubMed ID: 31858624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of screening on melanoma incidence and biopsy rates.
    Whiteman DC; Olsen CM; MacGregor S; Law MH; Thompson B; Dusingize JC; Green AC; Neale RE; Pandeya N;
    Br J Dermatol; 2022 Oct; 187(4):515-522. PubMed ID: 35531668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.
    Puliti D; Duffy SW; Miccinesi G; de Koning H; Lynge E; Zappa M; Paci E;
    J Med Screen; 2012; 19 Suppl 1():42-56. PubMed ID: 22972810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overdiagnosis in organised mammography screening in Denmark. A comparative study.
    Jørgensen KJ; Zahl PH; Gøtzsche PC
    BMC Womens Health; 2009 Dec; 9():36. PubMed ID: 20028513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.